News & Events

News

January 30, 2020

On January 23, Precision BioLogic was named Halifax’s Innovative Business of the Year at the 20th annual Halifax Business Awards.

The nomination and subsequent win recognize the 2019 launch of our CRYOcheck™ Factor VIII Inhibitor Kit along with our numerous poster publications and other educational activities to help labs deliver accurate results for the diagnosis and monitoring of FVIII inhibitors.

The award comes on the heels of the Canadian and EU launch of Precision BioLogic’s latest product, CRYOcheck™ Chromogenic Factor VIII.

January 20, 2020
Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the availability of its new CRYOcheck Chromogenic Factor VIII assay in Canada, the European Union, Australia, and New Zealand following market authorization by Health Canada and respective in-country regulatory authorities.
 
CRYOcheck Chromogenic Factor VIII is intended for use by clinical labs for the determination of FVIII activity in human plasma and as an aid in the management of hemophilia A. Studies1 have shown the chromogenic method to be less prone to interference from lipids or traces of heparin than clot-based FVIII activity tests, offering unsurpassed assurance in results, especially in cases of severe hemophilia A.
 

Events

Here’s a list of conferences we’ll be attending this year. If you’re planning on attending any of the same shows, be sure to swing by our booth for a chat because, after all, it’s you we want to see.

Apr 23 to 25
Chicago, IL – Visit PRECISION BIOLOGIC & AFFINITY BIOLOGICALS AT BOOTH 401
Jul 11 to 15
MILAN, ITALY - VISIT PRECISION BIOLOGIC & AFFINITY BIOLOGICALS AT BOOTH 11.32